Cem Onal

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 43

Top Topics

Locally Advanced

Radical Prostatectomy

Prostate Cancer

Renal Cell Carcinoma

Top Venues

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Cem Onal, Gungor Arslan, Cagdas Yavas, Esma Efe, Guler Yavas
Dosimetric evaluation of ultrafractionated dose escalation with simultaneous integrated boost to intraprostatic lesion using 1.5-Tesla MR-Linac in localized prostate cancer. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 29 (1) (2024)
Cem Onal, Ozan Cem Guler, Gurcan Erbay, Aysenur Elmali
The effect of dose-escalation radiotherapy with simultaneous-integrated-boost on the use of short-term androgen deprivation therapy in patients with intermediate risk prostate cancer. The Prostate 84 (8) (2024)
Cem Onal, Ozan Cem Guler, Gurcan Erbay, Aysenur Elmali
The effect of dose-escalation radiotherapy with simultaneous-integrated-boost on the use of short-term androgen deprivation therapy in patients with intermediate risk prostate cancer. The Prostate (2024)
Philip Sutera, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Phuoc T Tran, Matthew P Deek
PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer. The Prostate (2024)
Cem Onal, Ozan C Guler, Nese Torun, Aysenur Elmali, Philip Sutera, Matthew P Deek, Mehmet Reyhan, Melek Yavuz, Phuoc T Tran
Impact of definitive radiotherapy on metabolic response measured with 68 Ga-PSMA-PET/CT in patients with intermediate-risk prostate cancer. The Prostate (2024)
Cem Onal, Gungor Arslan, Cagdas Yavas, Esma Efe, Guler Yavas
Dosimetric evaluation of ultrafractionated dose escalation with simultaneous integrated boost to intraprostatic lesion using 1.5-Tesla MR-Linac in localized prostate cancer. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 29 (1) (2024)
Cem Onal, Birhan Demirhan, Aysenur Elmali, Ozan C Guler
Nomograms for detecting lymph node metastasis detected with surgery-Can you name any birds other than crow? The Prostate (2024)
Cem Onal, Aysenur Elmali
Letter to the editor regarding 'SBRT‑SG‑01: final results of a prospective multicenter study on stereotactic body radiotherapy for liver metastases'. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Aysenur Elmali, Ozan Cem Guler, Birhan Demirhan, Melek Yavuz, Cem Onal
Long-term analysis of hematological parameters as predictors of recurrence patterns and treatment outcomes in cervical cancer patients undergoing definitive chemoradiotherapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
Philip Sutera, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Phuoc T Tran, Matthew P Deek
PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer. The Prostate 84 (14) (2024)
Philip Sutera, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Phuoc T Tran, Matthew P Deek
PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer. The Prostate 84 (14) (2024)
Cem Onal, Recep Bozca, Ezgi Oymak, Ozan Cem Guler
Comparison of helical and TomoDirect techniques with simultaneous integrated boost in early breast cancer patients. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 28 (4) (2023)
Cem Onal, Ozan Cem Guler, Nese Torun, Ezgi Oymak, Mehmet Reyhan
The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [ 68 Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy. European journal of nuclear medicine and molecular imaging (2023)
Guler Yavas, Ozan Cem Guler, Melis Gultekin, Ezgi Oymak, Sezin Yuce Sari, Ferah Yildiz, Cem Onal
Multi-institutional study on the role of post-operative radiotherapy in elderly patients with endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Cem Onal, Gurcan Erbay, Ozan C Guler, Cagdas Yavas, Ezgi Oymak
Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patients. The Prostate (2023)
Cem Onal, Esma Efe, Recep Bozca, Cagdas Yavas, Guler Yavas, Gungor Arslan
The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac. Journal of applied clinical medical physics (2023)
Ezgi Oymak, Ozan Cem Guler, Cem Onal
Prognostic significance of albumin and globulin levels in cervical cancer patients treated with chemoradiotherapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)
Cem Onal, Ezgi Oymak, Ozan C Guler
There is no doubt about the winner of the lion-rabbit fight. The Prostate 82 (12) (2022)
Cem Onal, Pervin Hurmuz, Ozan Cem Guler, Guler Yavas, Burak Tilki, Ezgi Oymak, Cagdas Yavas, Gokhan Ozyigit
The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (8) (2022)
Cem Onal, Ezgi Oymak
Letter to the editor regarding 'Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY‑2 clinical trial subanalysis'. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (6) (2022)
Ozan Cem Guler, Cem Onal
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al. Journal of cancer research and clinical oncology 148 (9) (2022)
Sezin Yuce Sari, Ozan Cem Guler, Ezgi Oymak, Melis Gultekin, Ecem Yigit, Alper Kahvecioglu, Kunter Yuce, Husnu Celik, Alp Usubütün, Filiz Aka Bolat, Cem Onal, Ferah Yildiz
Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomes. The journal of obstetrics and gynaecology research 48 (7) (2022)
Cem Onal, Ozan Cem Guler, Pervin Hurmuz, Guler Yavas, Burak Tilki, Ezgi Oymak, Cagdas Yavas, Gokhan Ozyigit
Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 198 (10) (2022)
Cem Onal, Ezgi Oymak, Ozan Cem Guler, Burak Tilki, Guler Yavas, Pervin Hurmuz, Cagdas Yavas, Gokhan Ozyigit
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2022)
Yasemin Bölükbasi, Ezgi Oymak, Nilufer Kilic Durankus, Cem Onal
In regard to Boeri et al. 'Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience'. Prostate cancer and prostatic diseases (2022)
Cem Onal, Fatih Kose, Gokhan Ozyigit, Sercan Aksoy, Ezgi Oymak, Sadik Muallaoglu, Ozan C Guler, Burak Tilki, Pervin Hurmuz, Fadil Akyol
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment. The Prostate 81 (9) (2021)
Ezgi Oymak, Ozan Cem Guler, Cem Onal
Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2021)
Cem Onal, Ozan Cem Guler
Longer treatment time and lower radiation doses-an alternative for Graves' ophthalmopathy treatment. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2021)
Cem Onal, Sezin Yuce Sari, Guler Yavas, Ozan Cem Guler, Ecem Yigit, Ezgi Oymak, Melis Gultekin, Ferah Yildiz
Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapy. Future oncology (London, England) 17 (25) (2021)
Cem Onal, Ezgi Oymak, Ozan Cem Guler
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al. Medical oncology (Northwood, London, England) 38 (7) (2021)
Cem Onal, Ozan Cem Guler, Mehmet Reyhan, Ali Fuat Yapar
Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy. Journal of gynecologic oncology 32 (5) (2021)
Cem Onal, Guler Yavas, Cagdas Yavas
Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 197 (10) (2021)
Cem Onal, Gokhan Ozyigit, Ezgi Oymak, Ozan Cem Guler, Burak Tilki, Pervin Hurmuz, Fadil Akyol
Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients. European journal of nuclear medicine and molecular imaging 48 (11) (2021)
Cem Onal, Gokhan Ozyigit, Ezgi Oymak, Ozan Cem Guler, Pervin Hurmuz, Burak Tilki, Mehmet Reyhan, Murat Tuncel, Fadil Akyol
Clinical parameters and nomograms for predicting lymph node metastasis detected with 68 Ga-PSMA-PET/CT in prostate cancer patients candidate to definitive radiotherapy. The Prostate 81 (10) (2021)
Cem Onal, Recep Bozca, Yemliha Dolek, Ozan Cem Guler, Gungor Arslan
Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients. La Radiologia medica 125 (8) (2020)
Cem Onal, Melis Gultekin, Ezgi Oymak, Ozan Cem Guler, Melek Tuğce Yılmaz, Sezin Yuce Sari, Berna Akkus Yildirim, Ferah Yildiz
Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 30 (6) (2020)
Melis Gultekin, Ozan Cem Guler, Sezin Yuce Sari, Berna Akkuş Yıldırım, Cem Onal, Husnu Celik, Kunter Yuce, Ali Ayhan, Zafer Arik, Fatih Kose, Ozden Altundag, Teuta Zoto Mustafayev, Banu Atalar, Yasemin Bolukbasi, Ferah Yildiz
Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 41 (3) (2020)
Cem Onal, Ozan Cem Guler, Nese Torun, Mehmet Reyhan, Ali Fuat Yapar
The effect of androgen deprivation therapy on 68Ga-PSMA tracer uptake in non-metastatic prostate cancer patients. European journal of nuclear medicine and molecular imaging 47 (3) (2019)
Cem Onal, Sezin Yuce Sari, Berna Akkuş Yıldırım, Guler Yavas, Melis Gultekin, Ozan Cem Guler, Serap Akyurek, Ferah Yildiz
A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma. Journal of gynecologic oncology 30 (3) (2019)
Berna Akkus Yildirim, Cem Onal, Fatih Kose, Ezgi Oymak, Ali Murat Sedef, Ali Ayberk Besen, Sercan Aksoy, Ozan Cem Guler, Ahmet Taner Sumbul, Sadık Muallaoglu, Huseyin Mertsoylu, Gokhan Ozyigit
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 195 (10) (2019)
Cem Onal, Yemliha Dolek, Yurday Ozdemir
The impact of androgen deprivation therapy on setup errors during external beam radiation therapy for prostate cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 193 (6) (2017)
Cem Onal, Yemliha Dölek, Berna Akkuş Yıldırım
Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for postoperative gastric cancer patients. Japanese journal of radiology 36 (1) (2017)
Berna A Yildirim, Cem Onal, Yemliha Dolek
Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients? Japanese journal of radiology 35 (1) (2016)